78 results on '"FitzGerald, Garret A"'
Search Results
2. Differential Impact In Vivo of Pf4-ΔCre–Mediated and Gp1ba-ΔCre–Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice
3. Prostanoids in Cardiac and Vascular Remodeling
4. COX Postulates: Remember the Fibroblast
5. Abstract 14887: Sleep Disorders Increase the Risk for Calcific Aortic Stenosis
6. Abstract 12881: Lnc(RNA)-ing COX-2 and Cardioprotection: A PACERR Story
7. Cyclooxygenase-2, Asymmetric Dimethylarginine and the Cardiovascular Hazard from NSAIDs
8. Time-Dependent Hypotensive Effect of Aspirin in Mice
9. Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs
10. Urinary Prostaglandin Metabolites: An Incomplete Reckoning and a Flush to Judgment
11. Cyclooxygenase Inhibition: Pain, Inflammation, and the Cardiovascular System
12. Time for nonaddictive relief of pain
13. Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial
14. Conflict or Confluence of Interest?—Reply
15. Confluence, Not Conflict of Interest: Name Change Necessary
16. MEDICINE: Personalization in practice
17. BIOMEDICINE: Bringing PGE2 in from the cold
18. CIRCADIAN RHYTHMS: Temporal targets of drug action
19. I Prostanoid Receptor–Mediated Inflammatory Pathway Promotes Hepatic Gluconeogenesis Through Activation of PKA and Inhibition of AKT
20. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma
21. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function
22. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration
23. GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose–Exposure Relationships to Define Clinical Development Strategies
24. Loci influencing blood pressure identified using a cardiovascular gene-centric array
25. MEDICINE: Can Intellectual Property Save Drug Development?
26. Niacin and biosynthesis of PGD2 by platelet COX-1 in mice and humans
27. Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors
28. Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation
29. Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling
30. Drug development needs a new brand of science: We need to break with the past to develop new medicines, says Garret FitzGerald. An interdisciplinary NIH centre points the way.
31. Perestroika in Pharma: Evolution or Revolution in Drug Development?
32. Platelets, Pyrexia, and Plasmodia
33. COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice
34. WAVECLOCK: wavelet analysis of circadian oscillation
35. Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
36. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum–transfer arthritis
37. Prostacyclin receptor signaling and early embryo development in the mouse
38. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
39. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
40. Role of Prostacyclin versus Peroxisome Proliferator-Activated Receptor β Receptors in Prostacyclin Sensing by Lung Fibroblasts
41. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
42. Cardiovascular hazard and non-steroidal anti-inflammatory drugs
43. Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition
44. COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
45. Coxibs and Cardiovascular Disease
46. Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
47. Prostaglandins: Modulators of Inflammation and Cardiovascular Risk
48. Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation
49. Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
50. 8,12-iso-iPF2α-VI: The last word on oxidative stress?: Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.